Increased risk of gastrointestinal adverse effects under SSRI/NSAID combination may be due to pharmacokinetic interactions.
Zullino, Daniele Fabio
Increased risk of gastrointestinal adverse effects under SSRI/NSAID combination may be due to pharmacokinetic interactions. [electronic resource] - British journal of clinical pharmacology Jan 2005 - 118-9; author reply 119 p. digital
Publication Type: Comment; Letter
0306-5251
10.1111/j.1365-2125.2005.2212_1.x doi
Anti-Inflammatory Agents, Non-Steroidal--adverse effects
Antidepressive Agents, Tricyclic--adverse effects
Aryl Hydrocarbon Hydroxylases--antagonists & inhibitors
Cytochrome P-450 CYP2C9
Drug Combinations
Gastrointestinal Diseases--chemically induced
Humans
Selective Serotonin Reuptake Inhibitors--adverse effects
Increased risk of gastrointestinal adverse effects under SSRI/NSAID combination may be due to pharmacokinetic interactions. [electronic resource] - British journal of clinical pharmacology Jan 2005 - 118-9; author reply 119 p. digital
Publication Type: Comment; Letter
0306-5251
10.1111/j.1365-2125.2005.2212_1.x doi
Anti-Inflammatory Agents, Non-Steroidal--adverse effects
Antidepressive Agents, Tricyclic--adverse effects
Aryl Hydrocarbon Hydroxylases--antagonists & inhibitors
Cytochrome P-450 CYP2C9
Drug Combinations
Gastrointestinal Diseases--chemically induced
Humans
Selective Serotonin Reuptake Inhibitors--adverse effects